KATELYN WILLIS: Open Payments
NPI 1265735500 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $123 |
| Novo Nordisk Inc | 6 | $122 |
| Lilly USA, LLC | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Amgen Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Viatris Specialty LLC | 1 | $20 |
Products named: Wegovy, MOUNJARO, AIRSUPRA, BREZTRI, XIFAXAN, Ozempic, JARDIANCE, FARXIGA.
Industry payments across PA — which companies pay providers there.
